BCP-NC2-C12 is an ionizable cationic lipid employed in the formation of lipid nanoparticles (LNPs) for in vivo mRNA delivery. BCP-NC2-C12 LNPs, utilizing the CRISPR/Cas9 gene knockout method, achieve approximately a 90% reduction in serum PCSK9 protein levels.
Target:
Liposome
* VAT and and shipping costs not included. Errors and price changes excepted
